Siri H. StrandMichał ŚwitnickiMia MøllerChrista HaldrupTine M. StorebjergJakob HedegaardIver NordentoftS. HøyerMichael BorreJakob Skou PedersenPeter J. WildJong Y. ParkTorben F. ØrntoftKarina D. Sørensen
Methylation of the RHCG-TCAF1 panel adds significant independent prognostic value to established prognostic parameters for prostate cancer and thus may help to guide treatment decisions in the future. Further investigation in large independent cohorts is necessary before translation into clinical utility.
Kristensen, HelleHaldrup, ChristaStrand, SiriMundbjerg, KamillaMortensen, Martin MThorsen, KasperOstenfeld, Marie StampeWild, Peter JArsov, ChristianGoering, WolfgangVisakorpi, TapioEgevad, LarsLindberg, JohanGrönberg, HenrikHøyer, SørenBorre, MichaelOrntoft, Torben FSørensen, Karina D
Sami RaatikainenS. AaltomaaJorma J. PalvimoVesa KärjäYlermi Soini
Helle KristensenChrista HaldrupSiri H. StrandKamilla MundbjergMartin M. MortensenKasper ThorsenMarie S. OstenfeldPeter J. WildChristian ArsovWolfgang GoeringTapio VisakorpiLars EgevadJohan LindbergHenrik GrönbergS. HøyerMichael BorreTorben F. ØrntoftKarina D. Sørensen
Giovanni LughezzaniMassimo LazzeriAlberto AbrateElla KinzikeevaFrancesco Alessandro MistrettaNicolò Maria BuffiGiuliana ListaAlessandro LarcherNicola FossatiGiulio Maria GaddaPaolo Dell’OglioGiorgio Guazzoni
J.C. AnguloJosé I. LópezJuan F. DoradoManuel Sánchez‐ChapadoBegoña ColásSantiago Ropero